0
0
0
Therapeutic Fraud Prevention Act of 2023
3/14/2024, 7:39 AM
Summary of Bill S 2176
The Therapeutic Fraud Prevention Act of 2023, also known as Bill 118 s 2176, is a piece of legislation introduced in the US Congress aimed at preventing fraudulent practices in the field of therapy. The bill seeks to address the issue of so-called "conversion therapy," which is a widely discredited practice that claims to change an individual's sexual orientation or gender identity through therapy.
The bill specifically prohibits any person or entity from advertising, offering, or providing conversion therapy in exchange for monetary compensation. It also prohibits the use of any deceptive or misleading practices in the provision of therapy services related to sexual orientation or gender identity.
Additionally, the bill requires the Federal Trade Commission to enforce these provisions and investigate any complaints of violations. It also allows individuals who have been harmed by conversion therapy to seek civil remedies in court. Overall, the Therapeutic Fraud Prevention Act of 2023 aims to protect vulnerable individuals from harmful and fraudulent practices in the field of therapy, particularly those related to sexual orientation and gender identity.
The bill specifically prohibits any person or entity from advertising, offering, or providing conversion therapy in exchange for monetary compensation. It also prohibits the use of any deceptive or misleading practices in the provision of therapy services related to sexual orientation or gender identity.
Additionally, the bill requires the Federal Trade Commission to enforce these provisions and investigate any complaints of violations. It also allows individuals who have been harmed by conversion therapy to seek civil remedies in court. Overall, the Therapeutic Fraud Prevention Act of 2023 aims to protect vulnerable individuals from harmful and fraudulent practices in the field of therapy, particularly those related to sexual orientation and gender identity.
Read the Full Bill
Current Status of Bill S 2176
Bill S 2176 is currently in the status of Bill Introduced since June 22, 2023. Bill S 2176 was introduced during Congress 118 and was introduced to the Senate on June 22, 2023. Bill S 2176's most recent activity was Read twice and referred to the Committee on Commerce, Science, and Transportation. as of June 22, 2023
Bipartisan Support of Bill S 2176
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
68Democrat Cosponsors
62Republican Cosponsors
0Unaffiliated Cosponsors
6Policy Area and Potential Impact of Bill S 2176
Primary Policy Focus
CommerceAlternate Title(s) of Bill S 2176
Therapeutic Fraud Prevention Act of 2023
Therapeutic Fraud Prevention Act of 2023
A bill to prohibit commercial sexual orientation conversion therapy, and for other purposes.
Comments
Sponsors and Cosponsors of S 2176
Latest Bills
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2024-03: Unlawful and Unenforceable Contract Terms and Conditions".
Bill SJRES 128May 19, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Debt Collection Practices Act (Regulation F); Time-Barred Debt".
Bill SJRES 126May 19, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Examinations for Risks to Active-Duty Servicemembers and Their Covered Dependents".
Bill SJRES 132May 19, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2024-02: Deceptive Marketing Practices About the Speed or Cost of Sending a Remittance Transfer".
Bill SJRES 131May 19, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to withdrawal of the rule relating to "Consumer Financial Protection Circular 2024-05: Improper Overdraft Opt-In Practices".
Bill SJRES 130May 19, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2024-04: Whistleblower Protections Under CFPA Section 1057".
Bill SJRES 135May 19, 2026
Interagency Coordination in Export Controls Act of 2026
Bill HR 8036May 19, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Truth in Lending (Regulation Z); Use of Digital User Accounts to Access Buy Now, Pay Later Loans".
Bill SJRES 134May 19, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Credit Reporting; Name-Only Matching Procedures".
Bill SJRES 140May 19, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Truth in Lending (Regulation Z); Consumer Protections for Home Sales Financed Under Contracts for Deed".
Bill SJRES 149May 19, 2026
Therapeutic Fraud Prevention Act of 2023
Bill HR 4340February 5, 2024





